Synthesis and biological evaluation of new acinetoferrin homologues for use as iron transport probes in mycobacteria

Journal of Medicinal Chemistry

Volumn 47, Issue 20, 2004, Pages 4933-4940

  Gardner, Richard A ^a   Ghobrial, George ^a   Naser, Saleh A ^a   Phanstiel IV, Otto ^a  

^a UNIVERSITY OF CENTRAL FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACINETOFERRIN; ACINETOFERRIN DERIVATIVE; AEROBACTIN; ANTIBIOTIC AGENT; CARBOXYMYCOBACTIN; CITRIC ACID; DEFEROXAMINE; HYDROXAMIC ACID DERIVATIVE; IRON CHELATING AGENT; MYCOBACTIN J; NANNOCHELIN; SCHIZOKINEN; SIDEROPHORE; SUCCINIMIDE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL METABOLISM; CONTROLLED STUDY; DERIVATIZATION; DRUG COST; DRUG POTENCY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; IRON TRANSPORT; LINEAR SYSTEM; MYCOBACTERIUM AVIUM; MYCOBACTERIUM PARATUBERCULOSIS; NONHUMAN; STREPTOMYCES; STREPTOMYCES PILOSUS; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

BIOCHEMISTRY; BIOLOGICAL TRANSPORT; CELL DIVISION; CITRATES; DEFEROXAMINE; DRUG EVALUATION, PRECLINICAL; HYDROXAMIC ACIDS; IRON; IRON CHELATING AGENTS; MAGNETIC RESONANCE SPECTROSCOPY; MYCOBACTERIUM; MYCOBACTERIUM AVIUM; MYCOBACTERIUM PARATUBERCULOSIS; OXAZOLES;

EID: 4544380267     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm049805y     Document Type: Article

References (36)

1. (a) Bergeron, R. J.; Brittenham, G. M. The Development of Iron Chelators for Clinical Use; CRC Press: Boca Raton, FL, 1994; pp 279-284.
2. (b) Bergeron, R. J.; Brittenham, G. M. The Development of Iron Chelators for Clinical Use; CRC Press: Boca Raton, FL, 1994; p 258.
3. Roosenberg, J. M., II; Lin, Y.-M.; Lu, Y.; Miller, M. J. Studies and Syntheses of Siderophores, Microbial Iron Chelators, and Analogs as Potential Drug Delivery Agents. Curr. Med. Chem. 2000, 7, 159-197 and references therein.
4. Bergeron, R. J.; McManis, J. S.; Phanstiel, O., IV; Vinson, J. R. T. Total Synthesis of DFO. J. Org. Chem. 1995, 60, 109-114.
5. Bergeron, R. J.; Phanstiel, O., IV. The Total Synthesis of Nannochelin: A Novel Cinnamoyl Hydroxamate Containing Siderophore. J. Org. Chem. 1992, 57, 7140-7143.
6. Phanstiel, O., IV; Wang, Q. Total Synthesis of Acinetoferrin. J. Org. Chem. 1998, 63, 1491-1495.
7. 13C-NMR Spectroscopy. J. Prakt. Chem. 1987, 329 (3), 447-456.
8. Maurer, P. J.; Miller, M. J. Microbial iron chelators: total synthesis of aerobactin and its constituent amino acid, N6-acetyl-N6-hydroxylysine. J. Am. Chem. Soc. 1982, 104, 3096-3101.
9. Malouin, F.; Miller, M. J. Microbial Iron Chelators as Drug Delivery Agents: The Rational Design and Synthesis of Siderophore-Drug Conjugates. Acc. Chem. Res. 1993, 26, 241-249.
10. Lin, Y.; Helquist, P.; Miller, M. J. Synthesis and Biology Evaluation of a Siderophore-Virginiamycin Conjugate. Synthesis 1999, 1510-1514.
11. (a) World Health Organization. Global Tuberculosis Control; WHO Report WHO/CDS/TB/2001.287; WHO: Geneva, Switzerland, 2001.
12. (b) World Health Organization. Tuberculosis Fact Sheet, No. 104, 2000 (see http://www.who.int/inf-fs/en/fact104.html)
13. (a) Miller, M. J. Synthesis and Therapeutic Potential of Hydroxamic Acid Based Siderophores and Analogues. Chem. Rev. 1989, 89, 1563-1579;
14. (b) Haeym, B.; Honoré, N.; Truffot-Pernot, C.; Banerjee, A.; Schurra, C.; Jacobs, W. R., Jr.; van Embden, J. D. A.; Grosset, J. H.; Cole, S. T. Implications of Multidrug Resistance for the Future of Short Course Chemotherapy of Tuberculosis: A Molecular Study. Lancet 1994, 344, 293-298.
15. (a) Rouhi, A. M. Tuberculosis: A Tough Adversary. Chem. Eng. News 1999, May 17, 52-69.
16. (b) Xu, Y.; Miller, M. J. Total Syntheses of Mycobactin Analogues as Potent Antimycobacterial Agents Using a Minimal Protecting Group Strategy. J. Org. Chem. 1998, 63, 4314-4322.
17. (a) Connell, N. D.; Nikaido, H. Membrane Permeability and Transport in Mycobacterium Tuberculosis. In Tuberculosis: Pathogenesis, Protection, and Control; Bloom, B. R., Ed.; ASM Press: Washington, DC, 1994; p 333.
18. (b) Besra, G. S.; Chatterjee, D. Lipid and Carbohydrates of Mycobacterium Tuberculosis. In Tuberculosis: Pathogenesis, Protection, and Control; Bloom, B. R., Ed.; ASM Press: Washington, DC, 1994; p 285.
19. (a) McCullough, W. G.; Merkal, R. S. Structure of Mycobactin J. Curr. Microbiol. 1982, 7, 337-341.
20. (b) Mathews, P. R.; McDiarimid, J. A.; Collins, P.; Brown, A. The dependence of some strains of M. avium on mycobactin for initial and subsequent growth. J. Med. Microbiol. 1979, 11, 53-57.
21. (c) Lambrecht, R. S.; Collins, M. T. Mycobacterium paratuberculosis. Factors that influence mycobactin dependence. Diagn. Microbiol. Infect. Dis. 1992, 15 (3), 239-246.
22. (a) Maurer, P. J.; Miller, M. J. Total Synthesis of a Mycobactin: Mycobactin S2. J. Am. Chem. Soc. 1983, 105, 240-245.
23. (b) Hu, J.; Miller, M. J. Total Synthesis of a Mycobactin S, a Siderophore and Growth Promoter of Mycobacterium Smegmatis, and Determination of Its Growth Inhibitory Activity against Mycobacterium tuberculosis. J. Am. Chem. Soc. 1997, 119, 3462-3468.
24. (c) Hu, J. Total Synthesis of Mycobactins, Siderophore-Drug Conjugates and Biological Studies. Ph.D. Dissertation, Department of Chemistry and Biochemistry, University of Notre Dame, 1996.
25. (a) Barclay, R.; Ratledge, C. Iron binding compounds of M. avium, M. intracellularae, M. scrofulaceum, and mycobactin-dependent M. paratuberculosis and M. avium. J. Bacteriol. 1983, 153, 1138-1146.
26. (b) Chamberlin, W.; Graham, D. Y.; Hulten, K.; El-Zimaity, H. M. T.; Schwartz, M. R.; Naser, S.; Shafran, I.; El-Zaatari, F. A. K. Mycobacterium avium subsp. Paratuberculosis as one cause of Crohn's disease. Aliment Pharmacol. Ther. 2001, 15, 337-346.
27. (c) Chiodini, R. J.; Van Kruiningen, H. J.; Merkal, R. S. Ruminant paratuberculosis (Johne's Disease): The current status and future prospects. Cornell Vet. 1984, 74, 218-262.
28. Guo, H.; Naser, S. A.; Ghobrial, G.; Phanstiel, O., IV. Synthesis and Biological Evaluation of New Citrate-Based Siderophores as Potential Probes for the Mechanism of Iron Uptake in Mycobacteria. J. Med. Chem. 2002, 45, 2056-2063.
29. 5-hydroxy-L-ornithine from L-Ornithine. Synthesis 1990, 233-234.
30. Wang, Q. X.; King, J.; Phanstiel, O., IV. An Improved Synthesis of O-Benzoyl Protected Hydroxamates. J. Org. Chem. 1997, 62, 8104-8108.
31. Phanstiel, O., IV; Wang, Q. X.; Powell, D. H.; Ospina, M. P.; Leeson, B. A. Synthesis of Secondary Amines via N-(Benzoyloxy)amines and Organoboranes. J. Org. Chem. 1999, 64, 803-806.
32. Badescu, V. Synthesis and Thermal Study of a Series of N-Benzoyloxyamines and the Scope and Limitations of an Amine Oxidation Process. Masters Thesis, Department of Chemistry, University of Central Florida, 2000.
33. Wang, L.; Phanstiel, O., IV Synthesis of N-(Hydroxy)amide and N-(Hydroxy)thioamide-Containing Peptides. J. Org. Chem. 2000, 65, 1442-1447.
34. Naser, S. A.; Gillespie, R.; Naser, N. A.; El-Zaatari, F. A. K. Effect of IS900 gene of Mycobacterium paratuberculosis on Mycobacterium smegmatis. Curr. Microbiol. 1998, 37, 373-379.
35. Rastetter, W. H.; Erickson, T. J.; Venuti, M. C. Synthesis of iron chelators. Enterobactin, enantioenterobactin, and a chiral analog. J. Org. Chem. 1981, 46, 3579-3590.
36. Fadeev, E.; Luo, M.; Groves, J. T. Synthesis and characterization of acinetoferrin, schizokinen and their metal complexes. Abstr. Pap.-Am. Chem. Soc. 2002, 224 (August 18), 099-INOR.